Publications by authors named "Nicolas Solban"

Claim this Profile
D
Discovery and Evaluation of TLR-Targeted Immune Agonists.
Natalia Chernyak, Bhagyashree Bhagwat, Saraswathi Naravula, Ying Chen, Nicolas Solban

J Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRAS Inhibitor.
Xiaoshen Ma, David L Sloman, Ruchia Duggal, Kenneth D Anderson, Jeanine E Ballard, Nicolas Solban

J Med Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing.
Derun Li, David L Sloman, Abdelghani Achab, Hua Zhou, Meredeth A McGowan, Nicolas Solban

J Med Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors.
Brett Hopkins, Hongjun Zhang, Indu Bharathan, Derun Li, Qinglin Pu, Nicolas Solban

ACS Med Chem Lett· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
Amy G Aslamkhan, Qiuwei Xu, Amy Loughlin, Heather Vu, Stephen Pacchione, Nicolas Solban

Toxicol Appl Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive investigation of T and B cell receptor repertoires in an MC38 tumor model following murine anti‑PD‑1 administration.
Lu Zhang, I-Ming Wang, Nicolas Solban, Razvan Cristescu, Gefei Zeng

Mol Med Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors.
Qinglin Pu, Hongjun Zhang, Liangqin Guo, Mangeng Cheng, Amy C Doty, Nicolas Solban

ACS Med Chem Lett· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy.
Hongjun Zhang, Kun Liu, Qinglin Pu, Abdelghani Achab, Michael J Ardolino, Nicolas Solban

ACS Med Chem Lett· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMMD5/HCaRG Hooks Endosomes on Cytoskeleton and Coordinates EGFR Trafficking.
Carole G Campion, Kossay Zaoui, Thomas Verissimo, Suzanne Cossette, Hiroyuki Matsuda, Nicolas Solban

Cell Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma.
Xiaoen Wang, Nicolas Solban, Prateek Khanna, Marcella Callea, Jiaxi Song

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cortical-Bone Fragility--Insights from sFRP4 Deficiency in Pyle's Disease.
Pelin O Simsek Kiper, Hiroaki Saito, Francesca Gori, Sheila Unger, Eric Hesse, Nicolas Solban

N Engl J Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.
Marc Baud'huin, Nicolas Solban, Milton Cornwall-Brady, Dianne Sako, Yoshimi Kawamoto

Proc Natl Acad Sci U S A· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
Jonathan P Celli, Nicolas Solban, Alvin Liang, Stephen P Pereira, Tayyaba Hasan

Lasers Surg Med· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth.
Roselyne Castonguay, Eric D Werner, Robert G Matthews, Eleonora Presman, Aaron W Mulivor, Nicolas Solban

J Biol Chem· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.
Dianne Mitchell, Eileen G Pobre, Aaron W Mulivor, Asya V Grinberg, Roselyne Castonguay, Nicolas Solban

Mol Cancer Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment.
Sung K Chang, Imran Rizvi, Nicolas Solban, Tayyaba Hasan

Clin Cancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.
Boleslav Kosharskyy, Nicolas Solban, Sung K Chang, Imran Rizvi, Yuchiao Chang

Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted photodynamic therapy.
Nicolas Solban, Imran Rizvi, Tayyaba Hasan

Lasers Surg Med· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
Nicolas Solban, Pål K Selbo, Alok K Sinha, Sung K Chang, Tayyaba Hasan

Cancer Res· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCaRG increases renal cell migration by a TGF-alpha autocrine loop mechanism.
Carlos El Hader, Sandra Tremblay, Nicolas Solban, Denis Gingras, Richard Béliveau

Am J Physiol Renal Physiol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Bin Chen, Brian W Pogue, Xiaodong Zhou, Julia A O'Hara, Nicolas Solban

Clin Cancer Res· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo flow cytometry: a new method for enumerating circulating cancer cells.
Irene Georgakoudi, Nicolas Solban, John Novak, William L Rice, Xunbin Wei

Cancer Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCaRG is a novel regulator of renal epithelial cell growth and differentiation causing G2M arrest.
Alison M Devlin, Nicolas Solban, Sandra Tremblay, Jolanta Gutkowska, Walter Schürch

Am J Physiol Renal Physiol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis